S

Scryb Inc
CNSX:SCYB

Watchlist Manager
Scryb Inc
CNSX:SCYB
Watchlist
Price: 0.01 CAD
Market Cap: 3.2m CAD

Relative Value

There is not enough data to reliably calculate the relative value of SCYB.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SCYB Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
46
vs Industry
Median 3Y
19.6
Median 5Y
13.1
Industry
2.3
vs History
7
vs Industry
Median 3Y
-0.5
Median 5Y
-43.1
Industry
22
vs History
3
vs Industry
Median 3Y
-18.1
Median 5Y
-71.5
Industry
14.2
vs History
7
vs Industry
Median 3Y
-0.8
Median 5Y
-71
Industry
19.9
vs History
93
vs Industry
Median 3Y
1.2
Median 5Y
50.6
Industry
2.2
vs History
46
vs Industry
Median 3Y
19.7
Median 5Y
13.2
Industry
2.4
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
4.9
vs History
vs Industry
Median 3Y
-1.5
Median 5Y
-30.9
Industry
11.6
vs History
vs Industry
Median 3Y
-1.8
Median 5Y
-38.5
Industry
15.9
vs History
3
vs Industry
Median 3Y
-16.7
Median 5Y
-71
Industry
14.2
vs History
3
vs Industry
Median 3Y
-16.7
Median 5Y
-70.6
Industry
17.8
vs History
93
vs Industry
Median 3Y
1.1
Median 5Y
71.2
Industry
1.8

Multiples Across Competitors

SCYB Competitors Multiples
Scryb Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Scryb Inc
CNSX:SCYB
3.2m CAD 13.1 0.5 -1 -1.2
US
Abbott Laboratories
NYSE:ABT
231.4B USD 5.5 17.1 22.2 31.9
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.5B USD 21.6 76.1 61.4 74.6
US
Boston Scientific Corp
NYSE:BSX
153.6B USD 8.8 75.6 35.6 49.6
US
Stryker Corp
NYSE:SYK
150.8B USD 6.5 52.8 26 31.4
IE
Medtronic PLC
NYSE:MDT
114.6B USD 3.4 24.6 13.7 19.5
DE
Siemens Healthineers AG
XETRA:SHL
52.8B EUR 2.3 25.2 14.2 19.6
US
Becton Dickinson and Co
NYSE:BDX
50.9B USD 2.4 33.5 13.3 24.9
US
Edwards Lifesciences Corp
NYSE:EW
46.4B USD 8.4 11.1 25.4 28
US
IDEXX Laboratories Inc
NASDAQ:IDXX
43.7B USD 11.1 48.8 34.6 38.7
US
Resmed Inc
NYSE:RMD
37.9B USD 7.5 28.9 20.6 23.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
S
Scryb Inc
CNSX:SCYB
Average EV/EBITDA: 26.7
Negative Multiple: -1
N/A N/A
US
Abbott Laboratories
NYSE:ABT
22.2
13%
1.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
61.4
24%
2.6
US
Boston Scientific Corp
NYSE:BSX
35.6
21%
1.7
US
Stryker Corp
NYSE:SYK
26
12%
2.2
IE
Medtronic PLC
NYSE:MDT
13.7
7%
2
DE
Siemens Healthineers AG
XETRA:SHL
14.2
14%
1
US
Becton Dickinson and Co
NYSE:BDX
13.3
11%
1.2
US
Edwards Lifesciences Corp
NYSE:EW
25.4
12%
2.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
34.6
12%
2.9
US
Resmed Inc
NYSE:RMD
20.6
12%
1.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
S
Scryb Inc
CNSX:SCYB
Average EV/EBIT: 34.2
Negative Multiple: -1.2
N/A N/A
US
Abbott Laboratories
NYSE:ABT
31.9
22%
1.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
74.6
26%
2.9
US
Boston Scientific Corp
NYSE:BSX
49.6
31%
1.6
US
Stryker Corp
NYSE:SYK
31.4
16%
2
IE
Medtronic PLC
NYSE:MDT
19.5
15%
1.3
DE
Siemens Healthineers AG
XETRA:SHL
19.6
19%
1
US
Becton Dickinson and Co
NYSE:BDX
24.9
28%
0.9
US
Edwards Lifesciences Corp
NYSE:EW
28
12%
2.3
US
IDEXX Laboratories Inc
NASDAQ:IDXX
38.7
12%
3.2
US
Resmed Inc
NYSE:RMD
23.3
14%
1.7